Quercis Pharma

Quercis Pharma is a late clinical-stage biotech developing investigational therapies for urgent medical challenges, with the goal of bringing safe, effective, and affordable medicines to patients. Its homepage mission is healing without harm, and its highlights page describes Phase III assets with intellectual property extending through 2045. The pipeline includes a Phase 3 program for cancer-associated thrombosis under an FDA Special Protocol Agreement, plus work in sickle cell disease, ALS, COPD, and viral diseases.